The pharmaceutical wholesale industry is facing unprecedented challenges. Tariffs, IRA pricing reforms, and new drug legislation are disrupting supply chains, squeezing margins, and forcing wholesalers to rethink their strategies.
What’s at Risk?
- Tariffs may drive up costs on APIs, packaging, and medical devices.
- IRA-driven pricing shifts could reduce reimbursement rates and impact profitability.
- Supply chain vulnerabilities require new sourcing strategies to ensure product availability.
The pharmaceutical landscape is evolving, and those who act now will define the future. Get in-depth insights into how wholesalers can thrive amid market disruptions.
Download the Report
What if the biosimilar wave is just a ripple?
September 9, 2025
As biologics face a record-breaking patent cliff, the anticipated biosimilar wave may be more of a ripple than a wave. To thrive, life sciences firms must shift from solely pursuing speed to mastering precision.
ALVAREZ & MARSAL BOLSTERS ITS HEALTHCARE PRACTICE IN SOUTHEAST ASIA (ASEAN) REGION WITH THE APPOINTMENT OF SANATH KUMAR AS MANAGING DIRECTOR
September 1, 2025
Leading global professional services firm Alvarez & Marsal (A&M) has announced the appointment of Sanath Kumar as Managing Director within its Southeast Asia and Australia (SEAA) business unit. Based in Singapore, Mr. Sanath will play a strategic role in building out A&M’s Healthcare and Life Sciences practice across ASEAN markets.
Next-Generation Antibodies: A New Era in Immuno-Oncology
August 25, 2025
As the immune checkpoint inhibitor (ICI) market nears a patent cliff, the $50B immuno-oncology (IO) field is now seeking to surpass the limitations of earlier ICIs by enhancing survival outcomes, broadening coverage, and overcoming resistance mechanisms.
Strategic Patience in GenAI - A smarter path to AI leadership
August 11, 2025
As Generative AI accelerates across industries, life sciences firms must seek to adopt strategic patience, prioritizing long-term enterprise value over generating short-term media headlines.